| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/04/2023 | 3.96% | Morgan Stanley | $21 → $16 | Maintains | Equal-Weight |
| 05/04/2023 | 36.45% | Morgan Stanley | $23 → $21 | Maintains | Equal-Weight |
| 01/18/2023 | 49.45% | Morgan Stanley | $26 → $23 | Maintains | Equal-Weight |
| 11/02/2022 | 75.44% | Imperial Capital | → $27 | Downgrades | Outperform → In-Line |
| 10/17/2022 | 68.94% | Morgan Stanley | $32 → $26 | Maintains | Equal-Weight |
| 05/04/2022 | 107.93% | Morgan Stanley | $30 → $32 | Maintains | Equal-Weight |
| 02/16/2022 | 94.93% | Morgan Stanley | $31 → $30 | Maintains | Equal-Weight |
| 10/06/2021 | 101.43% | Morgan Stanley | $33 → $31 | Maintains | Equal-Weight |
| 09/21/2021 | 114.42% | Morgan Stanley | $36 → $33 | Maintains | Equal-Weight |
| 03/17/2021 | 114.42% | Morgan Stanley | → $33 | Initiates Coverage On | → Equal-Weight |
| 03/11/2021 | 94.93% | Roth Capital | → $30 | Downgrades | Buy → Neutral |
| 03/03/2021 | — | William Blair | Initiates Coverage On | → Market Perform | |
| 12/21/2020 | 81.94% | JP Morgan | → $28 | Initiates Coverage On | → Overweight |
| 06/08/2020 | -35.02% | Imperial Capital | $6 → $10 | Maintains | In-Line |
| 04/28/2020 | -61.01% | Imperial Capital | $12.5 → $6 | Downgrades | Outperform → In-Line |
| 02/28/2020 | -15.53% | Imperial Capital | $10 → $13 | Upgrades | In-Line → Outperform |
| 01/07/2020 | -2.53% | B of A Securities | → $15 | Upgrades | Neutral → Buy |
| 11/08/2019 | -31.77% | Imperial Capital | $12 → $10.5 | Downgrades | Outperform → In-Line |
| 10/24/2019 | -22.03% | Imperial Capital | $25 → $12 | Maintains | Outperform |
| 10/23/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 10/23/2019 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 08/13/2019 | 29.95% | Oppenheimer | $30 → $20 | Maintains | Outperform |
| 03/08/2019 | 55.95% | B of A Securities | $28 → $24 | Reiterates | Buy → Buy |
What is the target price for Resideo Technologies (REZI)?
The latest price target for Resideo Technologies (NYSE: REZI) was reported by Morgan Stanley on August 4, 2023. The analyst firm set a price target for $16.00 expecting REZI to rise to within 12 months (a possible 3.96% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Resideo Technologies (REZI)?
The latest analyst rating for Resideo Technologies (NYSE: REZI) was provided by Morgan Stanley, and Resideo Technologies maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Resideo Technologies (REZI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Resideo Technologies, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Resideo Technologies was filed on August 4, 2023 so you should expect the next rating to be made available sometime around August 4, 2024.
Is the Analyst Rating Resideo Technologies (REZI) correct?
While ratings are subjective and will change, the latest Resideo Technologies (REZI) rating was a maintained with a price target of $21.00 to $16.00. The current price Resideo Technologies (REZI) is trading at is $15.39, which is out of the analyst's predicted range.